Netherlands Travel Vaccine Market to 2032
Overview
The Netherlands Travel Vaccine Market is expected to reach a 179.94 USD Million by 2032 and is projected to grow at a CAGR of 10.71% from 2025 to 2032.
Revenue, 2024 (USD Million)
94.65
Forecast, 2032 (USD Million)
179.94
CAGR, 2024 - 2032
10.71%
Report Coverage
Netherlands
Netherlands Travel Vaccine Market 2018-2032 USD Million
Netherlands Travel Vaccine Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 94.65 USD Million
- Projected Market Size (2032): 179.94 USD Million
- CAGR (2025-2032): 10.71%
Key Findings of Netherlands Travel Vaccine Market
- The Netherlands Travel Vaccine Market was valued at 179.94 USD Million in 2024.
- The Netherlands Travel Vaccine Market is likely to grow at a CAGR of 10.71% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 77.53 USD Million
- The fastest growing segment Typhoid in Disease Segment grew Fastest with a CAGR of 18.67% during the forecast period from 2024 to 2032.
Netherlands Travel Vaccine Market Scope
Netherlands Travel Vaccine Market Segmentation & Scope
Composition
- Mono Vaccines
- Combination Vaccines
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Distribution Channel
- B2C
- B2B
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Netherlands Travel Vaccine Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 94.65 USD Million |
| Market Value in 2032 | 179.94 USD Million |
| CAGR (2025-2032) | 10.71% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Composition,Type,Patient Type,Gender,Route of Administration,Disease,Age Group,Distribution Channel,Category |
Regional Insights:
-
Leading Market (2024-2032): Netherlands, leading in terms of revenue 94.65 USD Million in 2024
- Key Country: Netherlands, leading in terms of revenue with value of 94.65 USD Million in 2024.
Segments and Scope
-
Netherlands Travel Vaccine Market to 2032, By Composition
- Combination Vaccines is the largest segment in Netherlands Travel Vaccine Market to 2032 with a revenue of 65.22 USD Million in the year 2024.
- Combination Vaccines is the Fastest growing segment in Netherlands Travel Vaccine Market to 2032 with a Growth rate of 10.86 % in forecast period 2025-2032.
-
Netherlands Travel Vaccine Market to 2032, By Type
- Inactivated Vaccines is the largest segment in Netherlands Travel Vaccine Market to 2032 with a revenue of 27.26 USD Million in the year 2024.
- Inactivated Vaccines is the Fastest growing segment in Netherlands Travel Vaccine Market to 2032 with a Growth rate of 11.81 % in forecast period 2025-2032.
-
Netherlands Travel Vaccine Market to 2032, By Patient Type
- Adult is the largest segment in Netherlands Travel Vaccine Market to 2032 with a revenue of 43.23 USD Million in the year 2024.
- Adult is the Fastest growing segment in Netherlands Travel Vaccine Market to 2032 with a Growth rate of 11.34 % in forecast period 2025-2032.
-
Netherlands Travel Vaccine Market to 2032, By Gender
- Male is the largest segment in Netherlands Travel Vaccine Market to 2032 with a revenue of 50.01 USD Million in the year 2024.
- Male is the Fastest growing segment in Netherlands Travel Vaccine Market to 2032 with a Growth rate of 10.93 % in forecast period 2025-2032.
-
Netherlands Travel Vaccine Market to 2032, By Route of Administration
- Injectable is the largest segment in Netherlands Travel Vaccine Market to 2032 with a revenue of 77.53 USD Million in the year 2024.
- Injectable is the Fastest growing segment in Netherlands Travel Vaccine Market to 2032 with a Growth rate of 10.85 % in forecast period 2025-2032.
-
Netherlands Travel Vaccine Market to 2032, By Disease
- Typhoid is the largest segment in Netherlands Travel Vaccine Market to 2032 with a revenue of 15.37 USD Million in the year 2024.
- Typhoid is the Fastest growing segment in Netherlands Travel Vaccine Market to 2032 with a Growth rate of 18.67 % in forecast period 2025-2032.
-
Netherlands Travel Vaccine Market to 2032, By Age Group
- 20-50 Years is the largest segment in Netherlands Travel Vaccine Market to 2032 with a revenue of 47.43 USD Million in the year 2024.
- 20-50 Years is the Fastest growing segment in Netherlands Travel Vaccine Market to 2032 with a Growth rate of 11.16 % in forecast period 2025-2032.
-
Netherlands Travel Vaccine Market to 2032, By Distribution Channel
- B2B is the largest segment in Netherlands Travel Vaccine Market to 2032 with a revenue of 73.38 USD Million in the year 2024.
- B2B is the Fastest growing segment in Netherlands Travel Vaccine Market to 2032 with a Growth rate of 10.87 % in forecast period 2025-2032.
-
Netherlands Travel Vaccine Market to 2032, By Category
- Recommended Vaccine is the largest segment in Netherlands Travel Vaccine Market to 2032 with a revenue of 44.56 USD Million in the year 2024.
- Recommended Vaccine is the Fastest growing segment in Netherlands Travel Vaccine Market to 2032 with a Growth rate of 11.12 % in forecast period 2025-2032.
Netherlands Travel Vaccine Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Pfizer Inc. | |||
| Sanofi | |||
| GSK plc. | |||
Netherlands Travel Vaccine Market Geographical Sales Distribution, 2018-2032 USD Million
Netherlands Travel Vaccine Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Netherlands Travel Vaccine Market is segmented based on Segmentation Composition,Type,Patient Type,Gender,Route of Administration,Disease,Age Group,Distribution Channel,Category.
Netherlands Travel Vaccine Market was valued at USD 94.65(Revenue in USD Million) in 2022.
Netherlands Travel Vaccine Market is projected to grow at a CAGR of 10.71% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the Netherlands Travel Vaccine Market, holding a largest market share of 77.53 USD Million in 2024
Netherlands Travel Vaccine Market Scope
Netherlands Travel Vaccine Market Segmentation & Scope
Composition
- Mono Vaccines
- Combination Vaccines
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Distribution Channel
- B2C
- B2B
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Frequently Asked Questions
The Netherlands Travel Vaccine Market is segmented based on Segmentation Composition,Type,Patient Type,Gender,Route of Administration,Disease,Age Group,Distribution Channel,Category.
Netherlands Travel Vaccine Market was valued at USD 94.65(Revenue in USD Million) in 2022.
Netherlands Travel Vaccine Market is projected to grow at a CAGR of 10.71% during the forecast period of 2024 to 2032.
The estimated market value of the Netherlands Travel Vaccine Market for final year is USD 179.94 (USD Million).
Netherlands Travel Vaccine Market Company Profiling
Frequently Asked Questions
The Netherlands Travel Vaccine Market is segmented based on Segmentation Composition,Type,Patient Type,Gender,Route of Administration,Disease,Age Group,Distribution Channel,Category.
Netherlands Travel Vaccine Market was valued at USD 94.65(Revenue in USD Million) in 2022.
Netherlands Travel Vaccine Market is projected to grow at a CAGR of 10.71% during the forecast period of 2024 to 2032.
The estimated market value of the Netherlands Travel Vaccine Market for final year is USD 179.94 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.